CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial Glucose-lowering Drugs or Strategies, Atherosclerotic Cardiovascular Events, and Heart Failure in People With or at Risk of Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Randomised Cardiovascular Outcome Trials Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus

Original Research2015 Jan 20;131(3):269-79.

JOURNAL:Circulation. Article Link

Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction

Shah SJ, Katz DH, Selvaraj S et al. Keywords: cluster analysis; echocardiography; heart failure, diastolic; patient outcome assessment

FULL TEXT PDF